Investor Overview

Who is Organovo?
  • We participate in attractive and growing markets with critical unmet needs
  • We benefit from favorable competitive dynamics and a first mover advantage
  • We’re a technology leader with a strong IP portfolio
  • We’re leveraging our technology platform to build a robust product and service platform across the preclinical safety, efficacy and disease modeling and therapeutic tissues markets
Investor Fact Sheet Investor Presentation

Stock Information
ONVO (Common Stock)
ExchangeNYSE (US Dollar)
Change (%) + 0.01 (0.38%)
Data provided by Nasdaq. Minimum 15 minutes delayed.
Stock chart for: ONVO.K.  Currently trading at $2.62 with a 52 week high of $5.82 and a 52 week low of $1.60.
Recent Investor News
Organovo and Its Customers Present Data Supporting 3D Bioprinted Liver Tissues for Drug Toxicity Testing and Liver Fibrosis Modeling
Organovo Announces Fiscal Third-Quarter Results; Company Updates Full-Year Fiscal 2016 Outlook and Affirms Long-Range Guidance
Investor Events
There are currently no events scheduled.
Featured Reports
2015 Annual Report
2015 Proxy Statement
Latest Tweets
Print Page Print Page | E-mail Page Email Page | RSS Feeds RSS Feeds | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet